Palo Alto Investors LP - Q3 2013 holdings

Add to watchlist

$954 Million is the total value of Palo Alto Investors LP's 34 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
STAA  STAAR Surgical Company$43,481,000
+33.4%
3,211,3180.0%4.56%
+18.5%
ALIM  Alimera Sciences, Inc.$13,668,000
-22.9%
3,634,9840.0%1.43%
-31.6%
FOLD  Amicus Therapeutics, Inc.$10,724,000
-0.4%
4,622,2300.0%1.12%
-11.6%
AVEO  AVEO Pharmaceuticals, Inc.$7,229,000
-17.6%
3,509,2050.0%0.76%
-26.8%
INSM  Insmed, Inc.$4,157,000
+30.5%
266,2990.0%0.44%
+16.0%
SPPI  Spectrum Pharmaceuticals Inc.$3,318,000
+12.3%
395,9850.0%0.35%
-0.3%
CYTK  Cytokinetics Inc.$1,980,000
-34.6%
261,5440.0%0.21%
-41.7%
PRTA  Prothena Corp PLC$1,790,000
+56.6%
88,5000.0%0.19%
+39.3%
NXTM  NxStage Medical, Inc.$581,000
-7.8%
44,1290.0%0.06%
-17.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2013-11-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Biomarin Pharmaceuticals, Inc42Q3 202316.6%
UNITED THERAPEUTICS CORP DEL42Q3 202315.3%
INSMED INC42Q3 202314.1%
STAAR Surgical Company42Q3 202311.8%
AMICUS THERAPEUTICS INC42Q3 202312.1%
VANDA PHARMACEUTICALS INC42Q3 20235.8%
PROTHENA CORP PLC42Q3 20239.1%
CYTOKINETICS INC40Q3 20230.4%
ALIGN TECHNOLOGY INC39Q3 20232.5%
ABIOMED INC38Q3 202217.1%

View Palo Alto Investors LP's complete holdings history.

Latest significant ownerships (13-D/G)
Palo Alto Investors LP Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ALIMERA SCIENCES INCSold outApril 03, 202300.0%
Epizyme, Inc.Sold outFebruary 14, 202300.0%
INSMED IncFebruary 14, 20235,871,2914.3%
Vanda Pharmaceuticals Inc.February 14, 20231,087,0641.4%
ALIMERA SCIENCES INCFebruary 14, 2022802,42311.6%
Clovis Oncology, Inc.February 14, 20223,997,8263.1%
STAAR SURGICAL COFebruary 14, 20221,140,5112.4%
Aimmune Therapeutics, Inc.Sold outFebruary 16, 202100.0%
AMAG PHARMACEUTICALS, INC.Sold outFebruary 16, 202100.0%
ALIMERA SCIENCES INCFebruary 14, 2020802,42416.2%

View Palo Alto Investors LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-04-03

View Palo Alto Investors LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Palo Alto Investors LP's holdings

CSVXLS